Accueil > Actualité
Actualite financiere : Actualite bourse

Equasens : Stifel remains confident in outlook

(CercleFinance.com) - Stifel has CONfirmed its 'buy' recommendation on Equasens shares, along with its E83 target price, following meetings with senior management which notably focused on short-term activity and the health of French pharmacies.


"While the short-term trading looks to be weaker than we hoped for when we upgraded the stock in early June (see our note), we continue to be confident in the potential for a recovery and for long-term growth", the broker says.

"With a change in momentum and higher growth rates in 2H24 and 2025, we continue to believe Equasens could re-rate to 15x EBITDA", Stifel adds.


Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.
 

societes

marches

tendances

 
Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.